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Background: Murine gammaherpesvirus 68 (HV-68) is an efficient pathogen, capable of infecting and establishing
lifelong latency in rodents. While many studies have demonstrated the ability of this viral infection to modulate
immune responses, a unifying mechanism for HV-68-induced subversion of a protective host response remains
elusive. We questioned whether infection with HV-68 could expand a population of myeloid derived suppressor
cells (MDSC) as one mechanism for altering protective immunity.
Methods: Mice were infected with HV-68, with viral latency being established in these animals. At varying times
post-infection, cells were isolated for detection of viral genomes, phenotyping of myeloid cell populations, and
ex vivo analysis of suppressor activity of myeloid cells.
Results: CD11b +Gr-1+ myeloid cells accumulated in the spleens, but not the bone marrow, of HV-68 infected
mice. These cells were predominantly Gr-1+ Ly-6 G+, and could be found to contain viral genomes. Increased levels
of serum S100A8/A9 produced during viral infection were consistent with the expansion of these CD11b +Gr-1+
myeloid cells. Despite their expansion, these cells exhibited no increased arginase 1 or iNOS activity, and did not
have the ability to suppress anti-CD3 antibody activated T lymphocyte responses.
Conclusions: We concluded that HV-68 infection was capable of expanding a population of myeloid cells which
were phenotypically similar to MDSC. However these cells were not sufficiently activated during the establishment
of viral latency to actively suppress T cell responses.
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Myeloid-derived suppressor cells (MDSC) are hemato-
poietic precursors of macrophages, granulocytes, and
dendritic cells [1]. These immature cells are CD11b +
Gr-1+ and can be found in normal bone marrow and
lymphoid organs. In response to inflammation [2], sepsis
[3], trauma[3], some autoimmune diseases [4], and some
cancers [5], the population of MDSC can be dramatically
expanded. These cells have been implicated in limiting
the immune response, with a particular focus on their
ability to suppress T lymphocyte activation [1]. Mechan-
isms of MDSC suppressive activity include the produc-
tion of arginase, iNOS, and reactive oxygen or nitrogen
species by these cells, as well as their ability to induce T
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reproduction in any medium, provided the orInduction of MDSC during microbial infections has
also been reported. Using a cecal ligation and puncture
model of bacterial sepsis, the presence of MDSC was
found to be beneficial for survival [3]. In parasitic infec-
tions [6], the expansion of MDSC may represent an at-
tempt by the host to balance harmful inflammation
while trying to eliminate the pathogen. In acute influ-
enza A infection, the presence of MDSC was thought to
be immunosuppressive [7]. A mouse model of hepatitis
B virus infection also suggested that the expansion of
MDSC and their immunosuppressive effect might con-
tribute to the chronic nature of this viral disease [8].
In the present study, we report the expansion of
CD11b +Gr-1+ cells following infection with murine
gammaherpesvirus 68 (HV-68). HV-68 has been used as
a model for studying the human gammaherpesviruses,
Epstein Barr virusand Kaposi’s sarcoma–associated her-
pesvirus[9]. This model seems quite useful based on theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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viruses, and on the similarities in pathologies induced in
infected mice. After intranasal or oral inoculation of
HV-68 in mice, there is a productive infection of epithe-
lial cells, followed by infection of B lymphocytes, macro-
phages and dendritic cells in peripheral organs like the
spleen. By days 9–11 post infection most of the infec-
tious virus is cleared, and a marked mononucleosis and
splenomegaly occurs which peaks around day 15 post-
infection. During this time the virus establishes latency,
with the long-term presence of the virus maintained
throughout the life of the animal. Many studies have
indicated that the immune response is altered following
the establishment of HV-68 latency in rodent models.
For example, chronic inflammatory conditions such as
EAE [10], inflammatory bowel disease [11], pulmonary
fibrosis [12], atherosclerotic lesions [13,14] are exacer-
bated in HV-68 infected mice. Such alterations in the in-
flammatory response could result from one or multiple
HV-68mediated alterations in the innate and adaptive
immune responses that have recently been reviewed [9].
At present the precise mechanisms, which allow HV-68
to subvert a protective host response and exacerbate in-
flammatory conditions, are not clear. In the present
study, we discovered that HV-68 could induce the accu-
mulation of cells with an MDSC phenotype in the
spleens of infected mice.
Materials and methods
Animals
Six to eight week old female BALB/c mice (18–22 g)
were purchased from Jackson Laboratories (Bar Harbor,
ME) and housed in the vivarium in filter top cages con-
taining sterile bedding. After arrival, mice were quaran-
tined for at least five days, and fed chow and water ad
libitum. All animal experiments were in compliance with
protocols approved by the University of North Carolina
at Charlotte Animal Care and Use Committee.
Maintenance of murine gammaherpesvirus-68 (HV-68)
stocks
Murine gammaherpesvirus-68 (HV-68; ATCC # VR-1465)
stocks were prepared by infecting baby hamster kidney
cells (BHK-21; ATCC # CCL-10) at a low multiplicity of in-
fection, followed by preparation of cellular lysates, as
described previously[15-17].Replicating HV-68 was quanti-
fied by adding 1:3 serial dilutions of cell media or lysates to
BALB/3 T12-3 cell (ATCC # CCL-164) monolayers. After
the monolayers were incubated with virus, cells were over-
layed with 1% plaqueassay agarose (BD Biosciences, San
Diego, CA) in medium with 30% fetal bovine serum. After
5 days in 5% CO2, overlays were removed and cell mono-
layers fixed and stained with crystal violet. All serial dilu-
tions were performed in triplicate.Nucleic acid isolation
Five to twenty-five milligrams of tissue or cells were sus-
pended in 250 μl of ice-cold phosphate-buffered saline
(PBS) and homogenized briefly in 1.5 ml microfuge
tubes. An equal volume of PBS containing 2% SDS,
10 mM EDTA and 50 μg/ml Proteinase K (Sigma-
Aldrich, St. Louis, MO) was added and homogenates
incubated overnight at 37oC. Nucleic acid was extracted
2X with saturated phenol/chloroform/isoamyl alcohol
(25:24:1), precipitated with 2 volumes of EtOH, and
resuspended in PBS with 25 μg/ml RNase A (Sigma-
Aldrich). After incubation for 30 min at 37oC, DNA was
extracted 1X with phenol/chloroform/isoamyl alcohol,
precipitated with 2 volumes ethanol, microfuged for
10 min at 16,000 × g and washed with 75% EtOH. The
DNA pellet was air dried and resuspended in 10 mM
Tris, pH 8.0. DNA concentration was determined by ab-
sorbance at 260 nm.
Total RNA was isolated using Trizol (Invitrogen;
Carlsbad, CA), as previously described[15,16,18]. RNA
samples were incubated with RNase-free pancreatic
DNase (RQ1 DNase, Promega, Madison, WI) as per the
manufacturer’s instructions, the RNA precipitated with
EtOH and resuspended in 50 μl of nuclease-free H2O.
RNA concentrations were determined with a Gene Spec
III spectrophotometer (Naka Instruments, Japan) using a
10 μl cuvette. For cDNA synthesis, one μg of RNA was
reverse-transcribed in the presence of random hexamers
(50 ng/μl), 10 mM dNTPs, 2.5 mM MgCl2 using
ImProm-II reverse transcriptase (Promega) in the buffer
supplied by the manufacturer. cDNA was precipitated
with one-tenth volume of 3 M sodium acetate (pH 5.2)
and 3 volumes of EtOH, and resuspended in 50 μl of
nuclease-free H2O.
Semiquantitative and quantitative PCR and RT-PCR
Genomic DNA and mRNA transcript levels were exam-
ined by PCR. For semiquantitative PCR, 100 ng of DNA or
cDNA was combined with 2.5 U of Taq polymerase (Pro-
mega), 0.2 mM each dNTP, 25 pmol of each primer and
PCR buffer containing 2.5 mM MgCl2 as provided by the
manufacturer. Samples were cycled using 95° denaturation
for 35 seconds, 60°C annealing for 75 seconds and 72°C ex-
tension for 90 seconds, with the first three cycles using
extended denaturation, annealing and extension times.
PCR was for 35 cycles, except for GAPDH, which was for
28 cycles. The extension time of the last cycle was for
5 min at 72°C. Forty percent of each amplified PCR prod-
uct was electrophoresed on an ethidium bromide-stained
2% agarose gel and photographed under UV illumination.
For quantitative PCR, mRNA expression was quantified
relative to GAPDH expression using an Applied Biosys-
tems 7500 Fast Real-time PCR System (FosterCity, CA)
and SYBR Green I for double-stranded DNA detection.
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containing QuantiTect SYBR Green PCR Master Mix
(Qiagen), primer pairs (0.5 μM), template cDNA (20 ng)
and nuclease-free water. Samples were cycled 45 times,
starting with an initial activation step of 15 min at 95°C,
followed by denaturation for 15 sec at 95°C, annealing for
30 sec at 60°C and extension for 30 sec at 72°C. Data were
acquired at 77°C for ORF65 and 80°C for GAPDH for
2 sec after extension.Changes in mRNA expression are








(GAPDH) Control – C (GAPDH) Sample) and CT= the thresh-
old cycle.
PCR primer sets were designed by using IDT SciTools
and purchased from IDT (Integrated DNA Technologies,
Coralville, IA). Primer sets used for amplification are as
follows:
ORF65(open reading frame-65 - murid herpesvirus 4;
accession no. NC_001826; 221 bp product)
Forward: 5’ - ATG CTC CAG AAG AGG AAG GGA
CAC - 3’
Reverse: 5’ - TTG GCA AAG ACC CAG AAG AAG
CC - 3’
TAAR1(trace amine-associated receptor 1 - accession
no.NM_053205; 159 bp product)
Forward: 5’ - ACT TCA ACC CAC CAA CTG GCT -
3’
Reverse: 5’ - AGC ATG ATA TCG GTG CTG GTG
TGA - 3’
ORF50 (open reading frame-50 - murid herpesvirus 4;
accession no. NC 001826; 355 bp)
Forward: 5’ – ATG GCA CAT TTG CTG CAG AAC -
3’
Reverse: 5’ – ACG GCG CCT GTG TAC TCA A – 3’
HV-68M3 (murid herpesvirus 4; accession no. NC
001826; 275 bp)
Forward: 5’ - TCT CTT GAC CCA GCT CTT CCA
CAG - 3’
Reverse: 5’ - AGG AGG ATT GGC TGA GAG CCT
TAC - 3’
GAPDH(glyceraldehyde-3-phosphate dehydrogenase;
accession no. NM_008084; 346 bp - spans exons 3to 5)
Forward: 5’ - CCA TCA CCA TCT TCC AGG AGC
GAG - 3’Reverse: 5’ –CAC AGT CTT CTG GGT GGC AGT
GAT-3’
HV-68 infection of mice, isolation of cells from tissues,and
FACS analyses
Groups of mice were anesthetized with isoflurane and
mock treated by intranasal instillation of saline, or
infected intranasally with 6 × 104plaque forming units
of HV-68 as previously described [15-17]. At the indi-
cated days post-infection, mice were euthanized and tis-
sues excised. Bone marrow cells were isolated from the
long bones of individual mice as previously described
[16,18,19]. Splenocyte single cell suspensions from indi-
vidual mice were made by passing tissue through a 30-
gauge wire mesh. Total spleen cells and bone marrow
cells were washed with sterile PBS (300 × g for
10 min), resuspended in PBS containing 10% non-
immune rabbit serum (Invitrogen, Camarillo, CA) and
incubated on ice for 45 min with antibodies conjugated
with appropriate fluorochromes for multiparameter
staining (anti-CD11b, anti-Gr-1, anti-Ly-6 G, and anti-
Ly-6 C; eBioscience, San Diego, CA).After washing, cells
were resuspended, analyzed, and then sorted using the
FACSAria II cell sorter (BD Biosciences,San Diego, CA).
Analyses were performed on >20,000 cells per individ-
ual spleen or bone marrow isolate. Cell subpopulations
(CD11b+, CD11B-, CD11B+Gr-1+, CD11B- Gr-1-, Gr-
1+ Ly-6 G+, and Gr-1+ Ly-6 C+) from individual mice
were sorted and cells pelleted at 1000 × g for nucleic
acid isolation.
S100A8 and S100A9 ELISA
Mice were uninfected or infected with HV-68 as
described above. At the indicated times post infection,
mice were euthanized and individual sera were taken.
The total amount of S100A8 and S100A9 in each serum
sample was determined using an ELISA capable of
detecting both proteins (ALPCO, Inc., Salem, NH).
Arginase 1 and iNOS activity
CD11b+ Gr-1+ cells were isolated using a mouse
Myeloid-Derived Suppressor Cell Isolation Kit (Miltenyi
Biotec, Auburn, CA). The isolated cells were cultured
for 24 hr in tissue culture medium (RPMI plus 10% fetal
bovine serum) and supernatants used for iNOS assays
and cells for arginase 1 assays.
The activity of arginase 1 was determined as follows:
Cells were lysed in 100 μl of 0.1% Triton X-100 for
30 min at 37°C, and microfuged to remove debris.
100 μl of 25 mM Tris–HCl (pH 7.4) and 10 μl of 10 μM
MnCl2 were added to the supernatant and incubated for
10 min at 56 °C. 100 μl of 0.5 ML-arginine (pH 9.5) was
added and incubate at 37°C for 30 min. The reaction
was stopped by the addition of 900 μl of 96% H2SO4,
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isonitrosopropiophenone (4% in EtOH) was added. Sam-
ples were heated at 95°C for 30 min along with serially
diluted urea standards. The absorbance was read at
570 nm.
The activity of iNOS was determined using the Griess
Reagent System (Promega, Madison, WI).MDSC isolation from HV-68 infected mice and co-culture
with activated T lymphocytes
For MDSC isolation, groups of mice were mock trea-
ted or infected with HV-68. At 15 days post infection,
mice were euthanized and spleens were removed. Sin-
gle cell suspensions of splenocytes were made as
described above, and red blood cells were removed
using a lysing reagent (Sigma-Aldrich, St. Louis, MO).
Splenic leukocytes were washed and resuspended in
RPMI-1640 containing 10% fetal bovine serum.Figure 1 Increased percentage of splenic CD11b+ Gr-1+ cells during t
were mock-treated or intranasally infected with HV-68 virus. During the pea
cells and splenocytes were isolated from individual animals and labeled wi
analysis of one representative animal per group shows the percentage of C
A) or spleen (Panel C) of a mock-treated mouse, or from the bone marrowCD11b +Gr-1 + cells were then isolated using a mouse
MDSC isolation kit (Miltenyi Biotec, Auburn, CA).
To isolate T lymphocytes, spleens were removed
from normal, uninfected mice, and splenic leukocytes
obtained as described above. Total T lymphocytes
were isolated using magnetic separation (Pan T cell
Isolation Kit; Miltenyi Biotec).
For co-cultures, the indicated numbers of MDSC
were added to 2 X 105 T lymphocytes in anti-CD3
coated microtiter wells (T cell activation plates, BD
Biosciences, Bedford, MA). After 72 hours of co-
incubation, the amount of IFN-γ present in the cul-
ture supernates was determined using an ELISA
(DuoSet mouse IFN-γ; R&D Systems, Minneapolis,
MN) as an indication of T lymphocyte activation.
Statistics
For statistical analysis, data were analyzed using GraphPad
Prism 5 software (GraphPad Software, Inc., San Diego,he leukocytosis phase of HV-68 infection. Groups ofBalb/c mice
k of viral-induced leukocytosis (15 days post-infection), bone marrow
th fluorchrome-conjugated anti-CD11b and anti-Gr-1 antibodies. FACS
D11b+ Gr-1+ cells (upper right quadrant) from thebone marrow (Panel
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Figure 2 Increased percentage of splenic CD11b+ Gr-1+ cells
during leukocytosis phase of HV-68 infection and during viral
latency. Groups of Balb/c mice were mock-treated or intranasally
infected with HV-68 virus. During the peak of viral-induced
leukocytosis (15 days post-infection) or after viral latency had been
established (30 days post-infection), bone marrow cells and
splenocytes were isolated from individual animals and labeled with
fluorchrome-conjugated anti-CD11b and anti-Gr-1 antibodies. FACS
analysis was performed to determine the percentage of CD11b+ Gr-
1+ cells in each cell population. Results are presented as mean
values (N = 5) ± standard errors for bone marrow cells (Panel A) or
spleen cells (Panel B).Asterisks indicate a statistically significant
difference (p< 0.05) when comparing Mock versus HV-68 infected
mice. These studies were performed three times with similar results.
To demonstrate viral latency in mice infected for 30 days (Panel C),
RNA isolated from spleens was subjected to RT-PCR to detect
expression of the M3 RNA (a latent transcript) and the lack of
expression of ORF 50 RNA (a replicating viral transcript).
Representative results of one animal (N = 5) are presented as
amplified products electrophoresed on ethidium bromide-stained
gels. Positive controls (+) for ORF50 and M3 amplifications are
shown in the last lane. Presence of GAPDH mRNA expression in
each RNA sample using RT-PCR was also performed as a positive
control.
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one-way analysis of variance (ANOVA) with Tukey’s Mul-
tiple Comparison Test as post-test. Mean values are pre-
sented in the figures +/− the standard error of the mean
(SEM). Results marked with an asterisk (*) were deter-
mined to be statistically significant at P< 0.05.Results
Increased percentage of splenic CD11b+ gr-1+ cells during
the leukocytosis phase of HV-68 infection
HV-68 infection results in a mononucleosis-like expansion
of leukocytes which peaks around 15 days post infection.
We questioned whether the number and percentage of
CD11b+Gr-1+ cells increased during this leukocytosis.
Figure 1 shows representative FACS analyses of bone mar-
row cells and splenocytes of one mock and one infected
animal. No significant difference was observed in the per-
centage of CD11b+Gr-1+ in the bone marrow of these
mice (Figure 1A, 27% versus 29%). However, there was a
significant increase in the percentage of CD11b+Gr-
1+ cells in the spleens of mice 15 days following infection
(Figure 1B, 4% versus 7%). In HV-68 infected mice, there is
a splenomegaly resulting from the mononucleosis-like
leukocytosis. This leukocytosis results in an increase in the
total splenic leukocytes isolated from mock (e.g. 6.2 X
107±1.1 X 107) versus infected (e.g. 1.8 X 108±1.8 X 107)
animals. Therefore, not only is the percentage of CD11b+
Gr-1+ cells in the spleens of HV-68 infected mice higher,
but the absolute number of these cells is also increased
during the mononucleosis-like disease.
Figure 2 shows cumulative data from 5 different mock
and HV-68 infected mice. No significant differences in the
percentage of CD11b+Gr-1+ in the bone marrow were
observed (Figure 2A). However, significant increases in the
percentage of CD11b+Gr-1+ in the spleens of infected
mice were observed (Figure 2B). Importantly, this differ-
ence was seen at day 15 post infection, but also at day 30
post-infection when leukocytosis was diminished. While
the latent viral transcript, M3, could be detected using RT-
Figure 3 Fractionation of CD11b+Gr1+ spleen cells into Ly-6 G
+ and Ly-6 G- populations. Groups of Balb/c mice were intranasally
infected with HV-68 virus, and at 15 days post-infection splenocytes
were isolated from individual animals. CD11b+Gr1+ cells were
isolated from these splenocytes, and labeled with fluorchrome-
conjugated anti-Ly-6 G and anti-Ly-6 C antibodies. FACS analysis was
performed to determine the percentage of each cell population.
Results are presented as mean values (N= 5) ± standard errors. These
studies were performed three times with similar results.





















Figure 5 HV-68 infection induces S100A8 and S100A9
production in vivo. Groups of mice were untreated (0) or infected
with HV-68(HV-68). At the indicated days post-infection sera was
taken and assayed for the presence of S100A8 and S100A9 using an
ELISA capable of recognizing either protein. Results are presented as
means (N= 6) ± standard errors, with asterisks indicating a statistically
significant difference (p< 0.05) when comparing untreated versus
HV-68 infected mice.
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could not be detected (Figure 2C). Therefore increased
percentages and numbers of CD11b+Gr-1+ cells that ac-
cumulate during the mononucleosis phase of the disease,
persist in the spleens of latently infected mice.
Fractionation of CD11b+Gr1+ spleen cells into ly-6 G
+ and ly-6 G- populations
To further define the phenotype of HV-68-expanded
CD11b+Gr1+ cells in the spleens of infected mice, these
cells were isolated and stained for the presence of Ly-6 G
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Figure 4 CD11b+Gr-1+ cells from spleens of HV-68 infected animals har
or intranasally infected with HV-68 virus (HV-68). During the peak of viral-induce
were isolated from individual animals and unfractionated (Spleen, Bone Marrow
or CD11b positive plus Gr1 positive (CDb+Gr-1+) cell populations. DNA was iso
by PCR. Representative results of one set of cell fractionations (N=3) are presen
gels. The presence of the Taar1 gene in each DNA sample using PCR was alsocells were Gr-1+ Ly-6 G+, with expansion of Gr1+ Ly-6 C
+cells being less frequent.
CD11b+gr-1+ cells from spleens of HV-68 infected
animals harbor HV-68 viral genomes
To question whether CD11b + and CD11b- populations
of cells harbored viral genomes, PCR for the DNA en-
coding HV-68 ORF 65 was performed. HV-68 ORF 65
DNA was detected in whole spleen (Figure 4, lane 3),
but not in bone marrow cells (Figure 4, lanes 5, 10, 11,
12, and 13). Splenic CD11b +Gr1+ (Figure 4 lanes 6 and









bor HV-68 viral genomes. Groups of Balb/c mice were mock-treated (M)
d leukocytosis (15 days post-infection), bone marrow cells and splenocytes
) or fractionated into CD11b positive (CD11b+), CD11b negative (CD11b-),
lated from each cell fraction and assayed for the presence of viral ORF65
ted as amplified products electrophoresed on ethidium bromide-stained
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Figure 6 CD11b+Gr-1+ cells from spleens of HV-68 infected
animals demonstrated no increase in arginase or iNOS activity.
Groups of mice were mock treated (M) or infected with HV-68 (HV-
68). During the peak of viral-induced leukocytosis (15 days post-
infection) or after viral latency had been established (30 days post-
infection), CD11b+Gr-1+ splenocytes were isolated from individual
animals. Arginase activity and iNOS production by these cells were
determined. Results are presented as means (N= 3) ± standard errors.
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65 DNA.
HV-68 infection induces S100A8 and S100A9 production
in vivo
Increased levels of S100A8 and S100A9 could be one
factor responsible for the increased number of CD11b +
Gr1+ cells in HV-68 infected mice [20]. To address this
possibility, serum levels of these proteins were quantified
at varying times following infection. Figure 5 shows in-
creasing serum levels of S100A8/S100A9 following infec-
tion with HV-68 which is consistent with the observed
expansion of CD11b +Gr1+ cells.
CD11b+gr-1+ cells from spleens of HV-68 infected animals
demonstrated no increase in arginase or iNOS activity
While it was clear that HV-68 infection increased the
number of CD11b +Gr1+ splenocytes, it could not be
assumed that these cells had suppressive abilities attribu-
ted to MDSC. Increased arginase 1 and iNOS activity
can contribute to the suppressive ability of some MDSC
[1]. Therefore we compared the levels of enzymatic ac-
tivity in CD11b+Gr-1+ spleen cells isolated from mock
treated or HV-68 infected mice. Figure 6 shows that
there was no increase in arginase 1 (Figure 6A) or iNOS
(Figure 6B) activity when comparing baseline activity
detected in mock treated animals to mice infected with
HV-68 for 15 or 30 days, respectively.
CD11b+gr-1+ cells from spleens of HV-68 infected
animals could not suppress anti-CD3 induced T cell
activation
To further investigate any potential suppressive ability of
HV-68-expanded CD11b +Gr-1+ splenocytes, T cell acti-
vation studies were performed. CD11b +Gr-1+ spleno-
cytes were isolated from mock treated mice or from
mice infected with HV-68 for 15 days. Limiting dilutions
of these cells were cultured with2 X 105 T lymphocytes
stimulated in anti-CD3 antibody coated microtiter wells.
Neither CD11b +Gr-1+ splenocytes isolated from mock
treated (Figure 7A) or HV-68 infected mice (Figure 7B)
could limit anti-CD3 antibody-induced T lymphocyte
IFN-γ secretion.
Discussion
HV-68 is an efficient pathogen, capable of infecting and
establishing lifelong latency in greater than 95% of
exposed rodents [21]. Clearly, this virus has evolved
mechanisms to limit a protective host response capable of
clearing acute or latent virus. Furthermore, increasing the
initial inoculum of virus does not result in dramatic
increases in pathophysiology, acute-virus mediated death,
or latent viral burden [21]. This fact also supports the no-
tion that HV-68 can control or limit the early hostresponse [22], favoring events which ultimately lead to
lifelong latency. It has been postulated that the dramatic
mononucleosis-like disease which develops, then resolves,
during the first 2–3 weeks post infection facilitates the es-
tablishment of this viral latency [9].
Mechanisms responsible for limiting protective im-
munity against HV-68 are not altogether clear. The initi-
ation of a relatively meager pro-inflammatory response
during the first few days post-infection has been noted
[22], and a listing of HV-68 induced effects on the innate
and adaptive immune response has recently been
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B       HV-68
Figure 7 CD11b+Gr-1+ cells from spleens of HV-68 infected
animals could not suppress anti-CD3 induced T cell activation.
Groups of mice were mock treated (Panel A) or infected with HV-68
(Panel B). During the peak of viral-induced leukocytosis (15 days
post-infection)CD11b+Gr-1+ cells were isolated from spleens of
individual mice. The indicated numbers of CD11b+Gr-1+ cells were
added to 2 X 105cultured T lymphocytes stimulated with anti-CD3
antibodies. After 72 hours of co-incubation, culture supernatants were
assayed for interferon gamma (IFN-γ) production as a measure of T cell
activation. Results are presented as means (N=3) ± standard errors.
Nelson et al. Journal of Inflammation 2012, 9:14 Page 8 of 10
http://www.journal-inflammation.com/content/9/1/14mechanism for HV-68-induced subversion of a protect-
ive host response remains elusive.
To further our understanding of how HV-68 infection
might limit a protective immune response following in-
fection, we analyzed the expansion of leukocytes during
the mononucleosis-like phase of the disease.In a previ-
ous publication, we demonstrated that CD11b + cells
were increased following HV-68 infection, and that this
population of cells could harbor virus [23]. However wedid not address whether this population of cells had a
phenotype or an activity consistent with an MDSC-
induced population.
Here we show that CD11b +Gr-1+ cells are
expanded in the spleens, but not bone marrow, of
mice infected with HV-68, consistent with the pheno-
type of MDSC (Figures. 1 and 2). Approximately two
thirds of these cells had a Gr1+ Ly6G+ phenotype,
giving these cells a granulocytic MDSC phenotype [1],
whereas the remainder have a monocytic MDSC
phenotype, Gr1+ Ly6G- Ly6C + (Figure 3). Of particu-
lar interest was the finding that the percentage of
MDSC remained expanded for at least 30 days post-
infection (Figure 2B). In these mice, no lytic viral
transcripts (e.g. ORF50) could be detected, but latent
viral transcripts (e.g. M3) were readily present
(Figure 2C). We concluded that HV-68 expanded
MDSC were present long after acute virus had been
cleared from these mice, and that MDSC continued
to be present during viral latency. The persistence of
increased numbers of MDSC during latency
(Figure 2B) could be due to the long-lived nature of
MDSC, as has been suggested [24]. Alternatively,
mechanisms resulting from infection with HV-68 may
contribute to their continued presence.
There are at least two mechanisms by which HV-68 in-
fection could induce MDSC expansion. First, these
CD11b+Gr1+ cells could be infected, and the interaction
of virus with pattern recognition receptors, or the induc-
tion of intracellular signaling pathways (e.g. NF-kB), might
contribute to MDSC expansion[1]. Clearly CD11b+Gr1+
cells harbor viral DNA (Figure 4). Future studies will be
required to define the percentage of MDSC which are
infected and the signaling pathways which might contrib-
ute to increasing cell numbers. Second, HV-68 infection
could induce the secretion of soluble factors which have
been documented to increase MDSC numbers[1]. Based
on previous studies, factors such as IL-6 [25], IL-12 [18],
and some chemokines [22]are unlikely to make a signifi-
cant contribution, since these proteins are not promin-
ently expressed in vivo following infection. However other
factors such as S100A8 and S100A9 can induce expansion
of MDSC, and it was not known whether HV-68 infection
could induce systemic expression of these molecules.
S100A8 and S100A9 are calcium-binding proteins that
form noncovalent homodimers and a heterodimer
(S100A8/A9) in a calcium-dependent manner[26]. These
proteins have been shown to be critically important for
the accumulation of MDSC in cancer models [20,27].
Here we show that following HV-68 infection, serum
levels of S100A8 or S100A9 increase during acute infec-
tion and are maintained during the establishment of viral
latency (Figure 5). The presence of such high levels of
S100A8 and S100A9 following infection, and the
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gests one likely mechanism to account for the accumula-
tion of HV-68 induced CD11b+Gr1+ cells in the spleen.
Expansion of MDSC does not necessarily indicate that
such cells are activated in a manner that allows them to
exert suppressive activity[1]. Mechanisms of MDSC sup-
pressive activity include the production of arginase,
iNOS, and reactive oxygen or nitrogen species by these
cells, as well as their ability to induce T regulatory cells
[1]. Isolated CD11b +Gr1+ from HV-68 infected mice
exhibited no increased arginase 1 (Figure 6A) or iNOS
activity (Figure 6B) when assayed ex vivo. Furthermore,
when dilutions of these cells were co-cultured with anti-
CD3 antibody activated T cells, no reduction in IFN-γ
production was observed (Figure 7). We concluded from
these studies that while HV-68 infection expanded a
CD11b +Gr-1+ population of spleen cells, these cells
were not fully activated to a suppressor phenotype.
In summary, HV-68 infection can expand a splenic
MDSC population, however these cells are not suffi-
ciently activated to function as suppressors. Therefore it
is unlikely that these expanded CD11b +Gr-1+ cells
make a significant contribution toward limiting a pro-
tective anti-viral immune response. Theoretically, how-
ever, if HV-68 infected mice were exposed to an
additional inflammatory insult which could activate
these MDSC, this expanded and activated cell popula-
tion might contribute to clinical disease. Future studies
will address the possibility that HV-68 infected mice
might exacerbate disease in cancer models via this
expanded CD11b +Gr-1+ cell population where acti-
vated MDSC contribute significantly to tumor burden
and metastasis.
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